Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 15 Source: CRO
- €463.8 million turnover
-
€33 million
profit - 3,554 employees
-
30th Sep 14 Source: CRO
- €432.7 million turnover
-
€16 million
profit - 3,297 employees
- 7 more years available »
Ranking
By Turnover
(€463.8 million)- 145th in Top Companies
- 18th in Health
- 19th in Pharma
By Employees
(3,554)- 57th in Top Companies
- 11th in Health
- 5th in Pharma
-
- 3,554
- €463.8 million
Employees
- Alan Armstrong CEO/Managing Director